A detailed history of National Bank Of Canada transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, National Bank Of Canada holds 452 shares of RPTX stock, worth $596. This represents 0.0% of its overall portfolio holdings.

Number of Shares
452
Previous 452 -0.0%
Holding current value
$596
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.75 - $3.99 $3,225 - $4,680
-1,173 Reduced 72.18%
452 $1,000
Q4 2023

Feb 06, 2024

SELL
$3.22 - $11.79 $644 - $2,358
-200 Reduced 10.96%
1,625 $11,000
Q3 2022

Oct 13, 2022

SELL
$11.57 - $15.59 $1,157 - $1,559
-100 Reduced 5.19%
1,825 $22,000
Q1 2022

May 05, 2022

SELL
$11.38 - $21.88 $1,138 - $2,188
-100 Reduced 4.94%
1,925 $27,000
Q4 2021

Jan 24, 2022

BUY
$19.66 - $28.11 $39,811 - $56,922
2,025 New
2,025 $43,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $55.4M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.